Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
JYNT vs USPH vs ENSG vs ACHC vs SEM
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
JYNT vs USPH vs ENSG vs ACHC vs SEM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $124M | $897M | $10.18B | $2.25B | $2.04B |
| Revenue (TTM) | $57M | $695M | $5.27B | $3.37B | $5.52B |
| Net Income (TTM) | $3M | $11M | $363M | $-1.11B | $134M |
| Gross Margin | 78.5% | 22.0% | 15.2% | 56.2% | 10.6% |
| Operating Margin | 1.1% | 12.2% | 8.5% | 11.7% | 5.8% |
| Forward P/E | 44.9x | 20.6x | 23.2x | 16.4x | 13.1x |
| Total Debt | $2M | $426M | $4.15B | $2.65B | $3.70B |
| Cash & Equiv. | $24M | $36M | $504M | $133M | $27M |
JYNT vs USPH vs ENSG vs ACHC vs SEM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Joint Corp. (JYNT) | 100 | 57.4 | -42.6% |
| U.S. Physical Thera… (USPH) | 100 | 79.6 | -20.4% |
| The Ensign Group, I… (ENSG) | 100 | 398.7 | +298.7% |
| Acadia Healthcare C… (ACHC) | 100 | 85.5 | -14.5% |
| Select Medical Hold… (SEM) | 100 | 189.2 | +89.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JYNT vs USPH vs ENSG vs ACHC vs SEM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JYNT lags the leaders in this set but could rank higher in a more targeted comparison.
USPH is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 5 yrs, beta 0.93, yield 3.1%
- 3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
ENSG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 7.5% 10Y total return vs SEM's 158.5%
- Lower volatility, beta 0.42, current ratio 1.42x
- Beta 0.42, yield 0.1%, current ratio 1.42x
Among these 5 stocks, ACHC doesn't own a clear edge in any measured category.
SEM ranks third and is worth considering specifically for value.
- Lower P/E (13.1x vs 16.4x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs ACHC's 5.0% | |
| Value | Lower P/E (13.1x vs 16.4x) | |
| Quality / Margins | 6.9% margin vs ACHC's -32.8% | |
| Stability / Safety | Beta 0.42 vs JYNT's 0.98 | |
| Dividends | 3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +27.5% vs USPH's -14.3% | |
| Efficiency (ROA) | 6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9% |
JYNT vs USPH vs ENSG vs ACHC vs SEM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
JYNT vs USPH vs ENSG vs ACHC vs SEM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SEM leads in 1 of 6 categories
JYNT leads 1 • ENSG leads 1 • USPH leads 0 • ACHC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — JYNT and USPH and ENSG each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SEM is the larger business by revenue, generating $5.5B annually — 97.5x JYNT's $57M. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $57M | $695M | $5.3B | $3.4B | $5.5B |
| EBITDAEarnings before interest/tax | $2M | $107M | $558M | $588M | $465M |
| Net IncomeAfter-tax profit | $3M | $11M | $363M | -$1.1B | $134M |
| Free Cash FlowCash after capex | $3M | $67M | $406M | -$215M | $117M |
| Gross MarginGross profit ÷ Revenue | +78.5% | +22.0% | +15.2% | +56.2% | +10.6% |
| Operating MarginEBIT ÷ Revenue | +1.1% | +12.2% | +8.5% | +11.7% | +5.8% |
| Net MarginNet income ÷ Revenue | +5.7% | +1.5% | +6.9% | -32.8% | +2.4% |
| FCF MarginFCF ÷ Revenue | +4.7% | +9.6% | +7.7% | -6.4% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.3% | +7.7% | +18.4% | +7.6% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +71.4% | -115.0% | +21.9% | -49.8% | -18.2% |
Valuation Metrics
SEM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 13.9x trailing earnings, SEM trades at a 69% valuation discount to JYNT's 45.6x P/E. On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than JYNT's 126.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $124M | $897M | $10.2B | $2.3B | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $103M | $1.3B | $13.8B | $4.8B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | 45.63x | 41.55x | 29.85x | -2.01x | 13.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 44.85x | 20.63x | 23.19x | 16.42x | 13.06x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.16x | — | — |
| EV / EBITDAEnterprise value multiple | 126.93x | 12.52x | 25.71x | 8.27x | 12.04x |
| Price / SalesMarket cap ÷ Revenue | 2.26x | 1.15x | 2.01x | 0.68x | 0.37x |
| Price / BookPrice ÷ Book value/share | 8.70x | 1.16x | 4.59x | 1.04x | 1.00x |
| Price / FCFMarket cap ÷ FCF | 370.99x | 14.71x | 27.46x | — | 5.33x |
Profitability & Efficiency
JYNT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JYNT delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. JYNT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), JYNT scores 6/9 vs SEM's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.9% | +1.4% | +16.6% | -40.9% | +6.6% |
| ROA (TTM)Return on assets | +5.0% | +0.9% | +6.8% | -18.6% | +2.3% |
| ROICReturn on invested capital | — | +5.6% | +7.0% | +5.9% | +4.8% |
| ROCEReturn on capital employed | -2.9% | +7.6% | +10.2% | +7.5% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.13x | 0.55x | 1.86x | 1.24x | 1.82x |
| Net DebtTotal debt minus cash | -$22M | $390M | $3.7B | $2.5B | $3.7B |
| Cash & Equiv.Liquid assets | $24M | $36M | $504M | $133M | $27M |
| Total DebtShort + long-term debt | $2M | $426M | $4.2B | $2.7B | $3.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 15.42x | 88.33x | -5.99x | 4.41x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $1,608 for JYNT. Over the past 12 months, ENSG leads with a +27.5% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs ACHC's -29.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -2.0% | -24.6% | +0.3% | +71.2% | +11.4% |
| 1-Year ReturnPast 12 months | -12.8% | -14.3% | +27.5% | +1.2% | +11.1% |
| 3-Year ReturnCumulative with dividends | -41.0% | -43.7% | +88.9% | -64.5% | +7.4% |
| 5-Year ReturnCumulative with dividends | -83.9% | -43.4% | +103.2% | -61.8% | -11.1% |
| 10-Year ReturnCumulative with dividends | +191.9% | +22.6% | +752.0% | -58.5% | +158.5% |
| CAGR (3Y)Annualised 3-year return | -16.1% | -17.4% | +23.6% | -29.2% | +2.4% |
Risk & Volatility
Evenly matched — ENSG and SEM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than JYNT's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs USPH's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.93x | 0.42x | 0.84x | 0.46x |
| 52-Week HighHighest price in past year | $13.47 | $93.50 | $218.00 | $30.20 | $16.99 |
| 52-Week LowLowest price in past year | $7.50 | $58.55 | $133.81 | $11.43 | $11.65 |
| % of 52W HighCurrent price vs 52-week peak | +64.4% | +63.1% | +80.0% | +81.0% | +96.8% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 46.1 | 23.3 | 46.2 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 57K | 171K | 358K | 3.1M | 2.1M |
Analyst Outlook
Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JYNT as "Buy", USPH as "Buy", ENSG as "Buy", ACHC as "Buy", SEM as "Hold". Consensus price targets imply 130.7% upside for JYNT (target: $20) vs -3.9% for ACHC (target: $24). For income investors, USPH offers the higher dividend yield at 3.06% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $20.00 | $102.00 | $222.33 | $23.50 | $18.00 |
| # AnalystsCovering analysts | 8 | 12 | 13 | 25 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% | +0.1% | — | +1.5% |
| Dividend StreakConsecutive years of raises | — | 5 | 12 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $1.80 | $0.24 | — | $0.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.1% | +0.6% | +0.2% | +2.2% | +4.9% |
SEM leads in 1 of 6 categories (Valuation Metrics). JYNT leads in 1 (Profitability & Efficiency). 3 tied.
JYNT vs USPH vs ENSG vs ACHC vs SEM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JYNT or USPH or ENSG or ACHC or SEM a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate The Joint Corp. (JYNT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JYNT or USPH or ENSG or ACHC or SEM?
On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.
9x versus The Joint Corp. at 45. 6x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x.
03Which is the better long-term investment — JYNT or USPH or ENSG or ACHC or SEM?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -83. 9% for The Joint Corp. (JYNT). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JYNT or USPH or ENSG or ACHC or SEM?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus The Joint Corp. 's 0. 98β — meaning JYNT is approximately 133% more volatile than ENSG relative to the S&P 500. On balance sheet safety, The Joint Corp. (JYNT) carries a lower debt/equity ratio of 13% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — JYNT or USPH or ENSG or ACHC or SEM?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: The Joint Corp. grew EPS 133. 9% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JYNT or USPH or ENSG or ACHC or SEM?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACHC leads at 11. 7% versus -1. 6% for JYNT. At the gross margin level — before operating expenses — JYNT leads at 76. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JYNT or USPH or ENSG or ACHC or SEM more undervalued right now?
On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.
1x forward P/E versus 44. 9x for The Joint Corp. — 31. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JYNT: 130. 7% to $20. 00.
08Which pays a better dividend — JYNT or USPH or ENSG or ACHC or SEM?
In this comparison, USPH (3.
1% yield), SEM (1. 5% yield), ENSG (0. 1% yield) pay a dividend. JYNT, ACHC do not pay a meaningful dividend and should not be held primarily for income.
09Is JYNT or USPH or ENSG or ACHC or SEM better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, ACHC: -58. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JYNT and USPH and ENSG and ACHC and SEM?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: JYNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock. USPH, SEM pay a dividend while JYNT, ENSG, ACHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.